TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Affibody Medical AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
17,285
|
20,367
|
27,840 |
| Financial expenses |
1,537
|
1,602
|
1,334 |
| Earnings before taxes |
-11,617
|
-14,535
|
-15,727 |
| EBITDA |
-8,684
|
-11,335
|
-12,809 |
| Total assets |
20,172
|
14,647
|
36,310 |
| Current assets |
13,388
|
7,295
|
26,937 |
| Current liabilities |
10,579
|
23,412
|
10,589 |
| Equity capital |
-6,141
|
-14,120
|
-3 |
| - share capital |
11,034
|
8,932
|
9,719 |
| Employees (average) |
90
|
91
|
83 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
-30.4%
|
-96.4%
|
0.0% |
| Turnover per employee |
192
|
224
|
335 |
| Profit as a percentage of turnover |
-67.2%
|
-71.4%
|
-56.5% |
| Return on assets (ROA) |
-50.0%
|
-88.3%
|
-39.6% |
| Current ratio |
126.6%
|
31.2%
|
254.4% |
| Return on equity (ROE) |
189.2%
|
102.9%
|
524233.3% |
| Change turnover |
-3,141
|
-5,218
|
16,000 |
| Change turnover % |
-15%
|
-20%
|
135% |
| Chg. No. of employees |
-1
|
8
|
11 |
| Chg. No. of employees % |
-1%
|
10%
|
15% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.